Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (603392.SS)
CNY 66.85
(-1.43%)
CNY 66.85
(-1.43%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 1.4 Billion CNY | -75.67% |
| 2022 | 5.59 Billion CNY | 140.33% |
| 2021 | 2.32 Billion CNY | 200.37% |
| 2020 | 775.2 Million CNY | 255.06% |
| 2019 | 218.33 Million CNY | -24.49% |
| 2018 | 289.12 Million CNY | 61.75% |
| 2017 | 178.74 Million CNY | 35.99% |
| 2016 | 131.43 Million CNY | 7.88% |
| 2015 | 121.84 Million CNY | 5.73% |
| 2014 | 115.23 Million CNY | 19.75% |
| 2013 | 96.23 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 17.35 Million CNY | 102.56% |
| 2024 Q3 | -8.1 Million CNY | -72.76% |
| 2024 Q2 | -27.89 Million CNY | -260.73% |
| 2023 Q4 | -677.74 Million CNY | -1084.26% |
| 2023 Q1 | 1.43 Billion CNY | 61.61% |
| 2023 FY | 1.36 Billion CNY | -75.67% |
| 2023 Q2 | 502.45 Million CNY | -64.95% |
| 2023 Q3 | 68.85 Million CNY | -86.3% |
| 2022 Q1 | 1.63 Billion CNY | 69.55% |
| 2022 Q4 | 887.07 Million CNY | -38.89% |
| 2022 Q3 | 1.45 Billion CNY | -10.69% |
| 2022 Q2 | 1.62 Billion CNY | -0.38% |
| 2022 FY | 5.59 Billion CNY | 140.33% |
| 2021 Q3 | 544.02 Million CNY | 12.11% |
| 2021 Q4 | 962.39 Million CNY | 76.9% |
| 2021 Q1 | 336.76 Million CNY | 57.76% |
| 2021 FY | 2.32 Billion CNY | 200.37% |
| 2021 Q2 | 485.26 Million CNY | 44.09% |
| 2020 Q3 | 276.23 Million CNY | 34.86% |
| 2020 Q1 | 80.65 Million CNY | 11.47% |
| 2020 FY | 775.2 Million CNY | 255.06% |
| 2020 Q2 | 204.83 Million CNY | 153.96% |
| 2020 Q4 | 213.47 Million CNY | -22.72% |
| 2019 Q2 | 47.51 Million CNY | 5.21% |
| 2019 Q3 | 53.29 Million CNY | 12.18% |
| 2019 FY | 218.33 Million CNY | -24.49% |
| 2019 Q4 | 72.35 Million CNY | 35.76% |
| 2019 Q1 | 45.15 Million CNY | 13.35% |
| 2018 Q1 | 26.72 Million CNY | 0.0% |
| 2018 FY | 289.12 Million CNY | 61.75% |
| 2018 Q4 | 39.83 Million CNY | -0.0% |
| 2018 Q3 | 39.83 Million CNY | 49.09% |
| 2018 Q2 | 26.72 Million CNY | 0.0% |
| 2017 FY | 178.74 Million CNY | 35.99% |
| 2016 FY | 131.43 Million CNY | 7.88% |
| 2015 FY | 121.84 Million CNY | 5.73% |
| 2014 FY | 115.23 Million CNY | 19.75% |
| 2013 FY | 96.23 Million CNY | 0.0% |